Browse the evidence

Statin therapy induces skeletal muscle toxicity and atrophy by upregulating the muscle-specific ubiquitin ligase atrogin-1/MAFbx, which mediates increased protein breakdown via the ubiquitin-proteasome pathway.

If you experience muscle pain or weakness while taking statins, it may not be 'in your head' but a specific biological response involving muscle breakdown proteins (atrogin-1). Do not simply stop the medication without consulting your doctor. Discuss testing for muscle enzymes (CK) and potential strategies to mitigate this, such as CoQ10 supplementation or switching to a less lipophilic statin, as the paper suggests these mechanisms are linked to mitochondrial function and specific gene expression.

Obesity-associated leptin resistance, driven by impaired BBB transport and intracellular signaling inhibition (PTP1B/SOCS3), contributes to cognitive decline and Alzheimer's disease pathology by disrupting synaptic plasticity and memory formation.

For those with obesity or aging-related cognitive concerns, addressing metabolic health is critical for brain health. The paper suggests that the failure of leptin signaling (leptin resistance) is a key driver of cognitive decline, not just high leptin levels. Interventions that improve metabolic health may help restore leptin sensitivity and protect against cognitive decline.

Adiponectin exerts neuroprotective effects by enhancing synaptic plasticity (LTP), reducing neuroinflammation, and improving insulin sensitivity, with low levels in obesity contributing to cognitive risk.

Maintaining healthy adiponectin levels through weight management and exercise is beneficial for brain health. Adiponectin helps reduce inflammation and improve insulin sensitivity in the brain, which supports memory and protects against cognitive decline.

Overweight males exhibit higher fasting and postprandial GLP-1 concentrations compared to lean males, yet this hormonal difference does not translate to a difference in subjective appetite ratings or actual energy intake.

If you are overweight, your body may produce more GLP-1 (a satiety hormone) after eating than a lean person, but this doesn't automatically make you feel fuller or eat less. This suggests your body might be less sensitive to this specific signal. However, consuming protein preloads can still effectively reduce your subsequent food intake, just as it does for lean individuals.

Long-term exclusive muscular strength training (minimum 12 months, no aerobic component) is associated with lower whole-body arterial compliance and higher pulse pressure compared to sedentary controls, indicating increased arterial stiffness.

If you exclusively perform heavy resistance training without any aerobic activity, your arteries may become stiffer and your pulse pressure higher compared to someone who is sedentary. This does not mean you should stop lifting, but it suggests that adding aerobic exercise may be necessary to maintain optimal arterial elasticity and reduce cardiovascular risk markers associated with stiffness.

Obstructive Sleep Apnea (OSA) independently exacerbates metabolic dysregulation (hypertriglyceridemia, hyperglycemia) and systemic inflammation (elevated C-reactive protein, uric acid) in patients with Metabolic Syndrome, regardless of the presence of daytime sleepiness.

If you have Metabolic Syndrome, you should be screened for Obstructive Sleep Apnea (OSA) even if you do not feel sleepy or snore loudly. Untreated OSA independently worsens your blood sugar, triglycerides, and inflammation. Treating OSA (e.g., with CPAP) may help improve these metabolic markers, so discuss sleep testing with your provider as part of your MetS management.

Palatability stimulates food intake through a distinct hedonic neural system that operates independently of homeostatic satiety signals, often leading to overconsumption even when sated.

Recognize that 'tasty' food triggers a reward system in your brain that is separate from your body's hunger signals. This means you can feel full but still be driven to eat more by the pleasure of the food. To manage intake, focus on reducing the hedonic appeal (palatability) of foods rather than just relying on feeling full.

Low-carbohydrate weight-loss diets decrease the concentration of microbially produced short-chain fatty acids and reduce the proportion of butyrate-producing bacteria.

If you are on a low-carb diet for weight loss, be aware that it may reduce beneficial gut bacteria and short-chain fatty acids. Try to include as much nondigestible carbohydrate (fiber) as possible within your dietary constraints to mitigate this.

Dietary antioxidant supplementation (specifically Vitamin E and C) does not improve muscular performance or endurance and may potentially increase mortality risk, contradicting the hypothesis that it protects against exercise-induced damage.

Avoid relying on Vitamin E or C supplements to boost exercise performance or protect muscles. Evidence shows they offer no performance benefit and Vitamin E supplementation has been linked to increased mortality in some reviews. Focus on whole foods for antioxidant needs.

Point-of-use micronutrient powders (MNPs) effectively reduce anemia and iron deficiency in children aged 6-24 months, but do not significantly impact growth.

For children aged 6-24 months in low-resource settings, use daily micronutrient powders (MNPs) sprinkled on food to prevent anemia and iron deficiency. Do not expect these powders to improve the child's height or weight.

AMPK is required for exercise-mediated glucose uptake in skeletal muscle, as complete abolition of AMPK activity leads to dramatic reductions in glucose uptake during exercise.

AMPK plays a crucial role in how your muscles take up glucose during exercise. If AMPK activity is completely blocked, glucose uptake during exercise is significantly reduced. This highlights the importance of maintaining healthy AMPK function through regular physical activity.

Rapid economic growth and urbanization drive a nutrition transition characterized by increased consumption of high-fat/high-carbohydrate energy-dense foods and sedentary behavior, leading to a sharp rise in obesity and chronic disease risk factors.

To combat rising obesity, individual efforts must be supported by environmental changes. This means prioritizing access to healthy foods and active transportation infrastructure, as relying solely on willpower is ineffective against aggressive marketing and sedentary urban design.

Elevated malonyl-CoA levels in skeletal muscle inhibit fatty acid oxidation and promote lipogenesis, contributing to insulin resistance in obese and type 2 diabetic subjects.

In insulin-resistant individuals, high levels of malonyl-CoA block fat burning and promote fat storage in muscle, worsening insulin resistance. This is driven by low AMPK activity and high ACC activity. While this paper focuses on mechanism, it suggests that interventions restoring AMPK activity (like exercise or specific medications) may help reverse these defects.

Rosiglitazone treatment reverses elevated malonyl-CoA levels, restores fatty acid oxidation, and improves insulin sensitivity in type 2 diabetic subjects.

For type 2 diabetics, rosiglitazone (4mg twice daily for 3 months) was shown to normalize malonyl-CoA levels and restore fatty acid oxidation. This suggests that pharmacological intervention can correct specific muscle metabolic defects associated with insulin resistance.

In obese, hirsute women with hyperinsulinemia, metformin administration provides no additional benefit to androgen profiles or SHBG levels beyond what is achieved by a low-calorie, low-fat diet alone.

If you are obese and have hirsutism with high insulin, focus on a low-calorie, low-fat diet. Adding metformin will not improve your hormone levels (SHBG, testosterone) any more than the diet does on its own. You may avoid the medication and its side effects (like diarrhea) without losing hormonal benefits.

Adding mobile diet monitoring apps and Twitter-based social support to a theory-based podcast weight-loss intervention does not enhance weight loss compared to the podcast alone.

If you are trying to lose weight, adding a calorie-counting app and a social media group to your routine may not give you any extra benefit if you are already following a structured plan. The study suggests that a simple, consistent plan (like listening to weekly podcasts) can be just as effective as a complex digital regimen, provided you stick to it. Do not assume that more technology equals better results.

Intra-abdominal (visceral) fat contributes to insulin resistance through mechanisms including high lipolytic activity, direct portal delivery of fatty acids to the liver, and secretion of inflammatory cytokines, whereas subcutaneous fat (particularly gluteofemoral) is metabolically protective.

Focus on reducing abdominal fat rather than just total body weight. Visceral fat is metabolically active and harmful, while subcutaneous fat (especially on hips/thighs) is protective. Strategies that reduce visceral fat (like exercise and specific dietary patterns) are more effective for improving insulin sensitivity than those that only reduce total mass.

Intramyocellular triglyceride (IMTG) levels are not the direct cause of muscle insulin resistance; instead, active lipid intermediates like diacylglycerol (DAG) and ceramides are the likely culprits, explaining why insulin-sensitive athletes can have high IMTG.

High fat content in muscles (IMTG) does not automatically mean you are insulin resistant. The key is how that fat is broken down into active byproducts like DAG and ceramides. Exercise can increase IMTG while improving insulin sensitivity by promoting healthy lipid partitioning.

Hepatic lipid accumulation contributes to insulin resistance through the activation of protein kinase C (PKC) by diacylglycerols (DAGs), but liver lipid can also be a consequence of hyperinsulinemia stimulating lipid synthesis pathways.

Reducing liver fat improves insulin sensitivity, but it's a two-way street: insulin resistance causes liver fat to accumulate, and liver fat worsens insulin resistance. Caloric restriction and carbohydrate reduction can rapidly improve hepatic insulin sensitivity by reducing fatty acid availability and DAG levels.

Men with diabetes mellitus have an approximately 3.5-fold higher prevalence of erectile dysfunction compared to men without diabetes, with severity correlating to the duration and complications of the disease.

If you have diabetes, erectile dysfunction is a common medical complication, not just a psychological issue. It is significantly more likely in diabetic men (3.5x higher risk) and often serves as an early warning sign for heart disease. You should discuss this with your doctor not just for sexual health, but as a critical check on your cardiovascular and metabolic status.

In postmenopausal breast cancer survivors, higher adiposity (BMI, body fat mass, waist circumference) is significantly associated with higher circulating levels of estrone, estradiol, testosterone, and free testosterone, and lower levels of sex hormone-binding globulin (SHBG).

For postmenopausal breast cancer survivors, maintaining a healthy body weight is crucial because excess body fat directly increases levels of estrogen and testosterone, which can fuel cancer growth. While you cannot change your genetics, managing body fat through diet and physical activity may help lower these hormone levels, potentially improving your prognosis. Focus on overall fat reduction rather than just waist size, as total body fat mass is the key driver.

Leptin resistance in obesity is primarily driven by impaired transport of leptin across the blood-brain barrier and intracellular signaling defects (specifically JAK2-STAT3 pathway inhibition by SOCS3 and PTP1B), rather than leptin deficiency.

If you are obese, your body likely produces plenty of leptin, but your brain is ignoring it. This is not because you lack the hormone, but because of biological 'noise' (inflammation, transport issues) blocking the signal. Simply taking leptin supplements is ineffective because the resistance mechanism prevents the hormone from acting on the brain. Focus on reducing the factors that cause this resistance, such as inflammation and high blood-brain barrier permeability issues, rather than seeking leptin replacement.

High serum leptin levels (>25-30 ng/mL) saturate the blood-brain barrier transport system, preventing leptin from entering the brain and thereby contributing to leptin resistance.

In obesity, the body produces so much leptin that it clogs the 'door' (blood-brain barrier) through which the hormone enters the brain. This saturation point means the brain stops receiving the 'full' signal, perpetuating hunger and weight gain. Reducing body fat may help lower leptin levels, potentially restoring the efficiency of this transport system.

Hypothalamic inflammation and endoplasmic reticulum stress are key drivers of leptin resistance, mediated by inflammatory cytokines like IL-6 and TNF-alpha induced by high-fat diets.

High-fat diets trigger inflammation in fat and liver tissue, which releases cytokines (IL-6, TNF-alpha) that disrupt leptin signaling in the brain. Managing inflammation through diet quality (reducing high-fat intake) may help restore leptin sensitivity.